This is the first study, to our knowledge, examining the ability of PPARγ activation to induce differentiation markers and to antagonize the TGF-β1-mediated changes associated with the EMT process in a human squamous carcinoma cell line. The gene discussed is PPARG; the disease is squamous cell carcinoma.